GLP-1 Receptor Agonists for Stroke Prevention in Type 2 Diabetes or Obesity.

Authors

• Drew Keister MD, Lehigh Valley Health NetworkFollow
• Mahvesh Shabbir MD, Lehigh Valley Health NetworkFollow
• Haidar Alwaeli MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

8-1-2026

Volume

114

Issue

2

First Page

187

Last Page

188

ISSN

1532-0650

Published In/Presented At

Keister, D., MD, Shabbir, M., MD, & Alwaeli, H., MD (2026). GLP-1 Receptor Agonists for Stroke Prevention in Type 2 Diabetes or Obesity. American family physician, 114(2), 187–188.

Disciplines

Medicine and Health Sciences

PubMedID

42789653

Department(s)

Department of Family Medicine, Department of Family Medicine Residents, Department of Family Medicine Faculty, Fellows and Residents

Document Type

Article